Stream Biomedical
Stream Biomedical is a clinical-stage biotechnology company developing first-in-class biologic therapies to restore neurological function by activating the brain’s natural repair mechanisms. Founded in 2016, the company is advancing a protein therapeutic focusing on treating brain injuries and neurodegenerative diseases—including stroke, traumatic brain injury, and Alzheimer’s disease—by supporting neurovascular repair and modulating inflammation. Stream Biomedical’s approach is underpinned by rigorous preclinical and translational research, with the goal of changing outcomes for patients affected by severe neurological conditions.
Industries
N/A
Products
A biologic therapy under development designed to restore natural brain repair mechanisms by targeting vascular dysfunction, inflammation, and neurovascular injury in acute and chronic CNS disorders.
A biologic therapy under development designed to restore natural brain repair mechanisms by targeting vascular dysfunction, inflammation, and neurovascular injury in acute and chronic CNS disorders.
Expertise Areas
- Neuroprotection and neurological repair
- Biologics development for CNS disorders
- Translational neuroscience research
- Blood-brain barrier biology
Key Technologies
- Protein biologics for neuroregeneration
- Animal models for CNS injury
- Blood-brain barrier integrity assays
- Behavioral and functional neuroassays
Key People
Chief Executive Officer
Chief Scientific Officer
Director of Translational Programs
Senior Process Engineer
Scientific Advisory Board Member
Scientific Advisory Board Member
Chief Executive Officer
Chief Scientific Officer
Director of Translational Programs
Senior Process Engineer
Scientific Advisory Board Member
Scientific Advisory Board Member
News & Updates
Scientific presentations of preclinical and translational findings for regenerative biologic therapy at the 2025 ASENT annual meeting.
Scientific presentations of preclinical and translational findings for regenerative biologic therapy at the 2025 ASENT annual meeting.